新生児スクリーニングのアジア市場予測2018-2026

◆英語タイトル:ASIA PACIFIC NEWBORN SCREENING MARKET FORECAST 2018-2026
◆商品コード:INKW803063
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2108年2月19日
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アジア
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGSThe Asia-Pacific newborn screening market contributed $105 million in 2017. By the end of the forecast period of 2018-2026, the market is predicted to rise with 14.11% CAGR and generate a revenue share of $333 million.
MARKET INSIGHTS
The Japanese newborn screening market contributed the highest revenue share in 2017. However, it is the South Korean market that is expected to progress with the fastest CAGR over the forecast period. Other significant markets in this region include India, China, Australia and rest of Asia-Pacific. Factors like rising awareness for pediatric congenital heart disease and increase in the number of pregnant women with advanced maternal age are expected to drive the market growth in this region. Newborn screening reagents and assay kits are expected to be the more popular product category in this market. However, a lack of skilled professionals to safely carry out these screenings is a major challenge faced by this market.
COMPETITIVE INSIGHTS
Market players like Neogen Labs Pvt. Ltd, Agilent Technology Inc, Masimo Corporation, Bio-Rad Laboratories Inc, Biotek Instruments Inc, Trivitron Healthcare, Thermo Fisher Scientific Inc, Natus Medical Incorporated, Zen Tech Sa, Waters Corporation, GE Healthcare, and Medtronic Plc are well-known in this region.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. NEWBORN SCREENING INSTRUMENTS DOMINATES THE PRODUCTS SEGMENT
3.2.2. DRY BLOOD SPOT TEST: DOMINATES THE TEST TYPE SEGMENT
3.2.3. DECREASING MORTALITY RATE
4. MARKET DYNAMICS
4.1. MARKET DEFINITION
4.2. DRIVERS
4.2.1. INCREASING PREVALENCE OF NEWBORN DISEASES
4.2.2. GROWING INCIDENCE OF FETAL HEALTH-RELATED ABNORMALITIES
4.2.3. GOVERNMENT SUPPORT TOWARDS NEWBORN CHILD HEALTH
4.2.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
4.2.5. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
4.2.6. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
4.3. RESTRAINTS
4.3.1. LACK OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
4.3.2. SOCIO-ECONOMIC BARRIERS IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
4.4. OPPORTUNITY
4.4.1. INCREASING FERTILITY RATES ACROSS THE GLOBE
4.4.2. UNTAPPED OPPORTUNITY IN DEVELOPING COUNTRIES
4.5. CHALLENGES
4.5.1. LACK OF SKILLED PROFESSIONAL
5. MARKET BY PRODUCT TYPE
5.1. NEWBORN SCREENING INSTRUMENTS
5.1.1. HEARING SCREENING INSTRUMENTS
5.1.2. NEWBORN DISORDER SCREENING INSTRUMENTS
5.1.3. PULSE OXIMETRY
5.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
6. MARKET BY TEST TYPE
6.1. HEARING SCREENING TEST
6.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
6.3. DRY BLOOD SPOT TEST
7. MARKET BY TECHNOLOGY
7.1. HEARING SCREEN TECHNOLOGY
7.2. ELECTROPHORESIS
7.3. TANDEM MASS SPECTROMETRY
7.4. PULSE OXIMETRY TECHNOLOGY
7.5. DNA BASED ASSAYS
7.6. ENZYMES & IMMUNOASSAYS
8. KEY ANALYTICS
8.1. PORTERS 5 FORCE ANALYSIS
8.1.1. THREATS OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. KEY BUYING CRITERIA
8.2.1. RELIABILITY
8.2.2. COST
8.2.3. AVAILABILITY
8.2.4. TECHNOLOGICAL ADVANCEMENT
8.3. VALUE CHAIN ANALYSIS
8.3.1. RAW MATERIAL SUPPLIERS
8.3.2. MANUFACTURERS
8.3.3. DISTRIBUTORS
8.3.4. END-USERS
8.4. REGULATORY FRAMEWORK
8.5. INVESTMENT OUTLOOK
8.5.1. COUNTRY OUTLOOK
8.5.2. INVESTMENT OUTLOOK
9. GEOGRAPHICAL ANALYSIS
9.1. CHINA
9.2. INDIA
9.3. JAPAN
9.4. AUSTRALIA
9.5. REST OF ASIA-PACIFIC
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.1.1. PERKINELMER, INC.
10.1.2. BIO-RAD LABORATORIES
10.1.3. TRIVITRON HEALTHCARE
10.1.4. AGILENT TECHNOLOGIES INC.
10.2. TOP WINNING STRATEGIES
10.3. COMPANY PROFILES
10.3.1. AB SCIEX LLC (U.S.) (ACQUIRED BY DANAHER)
10.3.1.1. OVERVIEW
10.3.1.2. PRODUCT PORTFOLIO
10.3.1.3. STRATEGIC INITIATIVES
10.3.1.4. SCOT ANALYSIS
10.3.1.5. STRATEGIC ANALYSIS
10.3.2. BIOTEK INSTRUMENTS INC.
10.3.2.1. OVERVIEW
10.3.2.2. PRODUCT PORTFOLIO
10.3.2.3. SCOT ANALYSIS
10.3.2.4. STRATEGIC ANALYSIS
10.3.3. BIO-RAD LABORATORIES INC.
10.3.3.1. OVERVIEW
10.3.3.2. PRODUCT PORTFOLIO
10.3.3.3. STRATEGIC INITIATIVES
10.3.3.4. SCOT ANALYSIS
10.3.3.5. STRATEGIC ANALYSIS
10.3.4. CARDINAL HEALTH INC.
10.3.4.1. OVERVIEW
10.3.4.2. PRODUCT PORTFOLIO
10.3.4.3. SCOT ANALYSIS
10.3.4.4. STRATEGIC ANALYSIS
10.3.5. GE HEALTHCARE
10.3.5.1. OVERVIEW
10.3.5.2. PRODUCT PORTFOLIO
10.3.5.3. SCOT ANALYSIS
10.3.5.4. STRATEGIC ANALYSIS
10.3.6. AGILENT TECHNOLOGY INC
10.3.6.1. OVERVIEW
10.3.6.2. PRODUCT PORTFOLIO
10.3.6.3. STRATEGIC INITIATIVES
10.3.6.4. SCOT ANALYSIS
10.3.6.5. STRATEGIC ANALYSIS
10.3.7. MASIMO CORPORATION
10.3.7.1. OVERVIEW
10.3.7.2. PRODUCT PORTFOLIO
10.3.7.3. STRATEGIC INITIATIVES
10.3.7.4. SCOT ANALYSIS
10.3.7.5. STRATEGIC ANALYSIS
10.3.8. NATUS MEDICAL INCORPORATED
10.3.8.1. OVERVIEW
10.3.8.2. PRODUCT PORTFOLIO
10.3.8.3. STRATEGIC INITIATIVES
10.3.8.4. SCOT ANALYSIS
10.3.8.5. STRATEGIC ANALYSIS
10.3.9. MEDTRONIC PLC
10.3.9.1. OVERVIEW
10.3.9.2. PRODUCT PORTFOLIO
10.3.9.3. SCOT ANALYSIS
10.3.9.4. STRATEGIC ANALYSIS
10.3.10. THERMO FISHER SCIENTIFIC INC.
10.3.10.1. OVERVIEW
10.3.10.2. PRODUCT PORTFOLIO
10.3.10.3. SCOT ANALYSIS
10.3.10.4. STRATEGIC ANALYSIS
10.3.11. NEOGEN LABS PVT. LTD.
10.3.11.1. OVERVIEW
10.3.11.2. PRODUCT PORTFOLIO
10.3.11.3. STRATEGIC INITIATIVES
10.3.11.4. SCOT ANALYSIS
10.3.11.5. STRATEGIC ANALYSIS
10.3.12. PERKINELMER INC.
10.3.12.1. OVERVIEW
10.3.12.2. PRODUCT PORTFOLIO
10.3.12.3. STRATEGIC INITIATIVES
10.3.12.4. SCOT ANALYSIS
10.3.12.5. STRATEGIC ANALYSIS
10.3.13. ZEN TECH SA
10.3.13.1. OVERVIEW
10.3.13.2. PRODUCT PORTFOLIO
10.3.13.3. SCOT ANALYSIS
10.3.13.4. STRATEGIC ANALYSIS
10.3.14. WATERS CORPORATION
10.3.14.1. OVERVIEW
10.3.14.2. PRODUCT PORTFOLIO
10.3.14.3. STRATEGIC INITIATIVES
10.3.14.4. SCOT ANALYSIS
10.3.14.5. STRATEGIC ANALYSIS
10.3.15. TRIVITRON HEALTHCARE
10.3.15.1. OVERVIEW
10.3.15.2. PRODUCT PORTFOLIO
10.3.15.3. STRATEGIC INITIATIVES
10.3.15.4. SCOT ANALYSIS
10.3.15.5. STRATEGIC ANALYSIS

LIST OF TABLES
TABLE 1 ASIA PACIFIC NEWBORN SCREENING MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 ASIA PACIFIC INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS
TABLE 3 ASIA PACIFIC NEWBORN SCREENING MARKET BY PRODUCT 2018-2026 ($ MILLION)
TABLE 4 ASIA PACIFIC NEWBORN SCREENING INSTRUMENTS MARKET SUB SEGMENTS 2018-2026 ($ MILLION)
TABLE 5 ASIA PACIFIC NEWBORN SCREENING MARKET BY TEST TYPE 2018-2026 ($ MILLION)
TABLE 6 ASIA PACIFIC NEWBORN SCREENING MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
TABLE 7 ASIA-PACIFIC NEWBORN SCREENING MARKET BY COUNTRY 2018-2026 ($ MILLION)

LIST OF FIGURES
FIGURE 1 ASIA PACIFIC NEWBORN SCREENING MARKET BY PRODUCT TYPE 2018-2026 ($ MILLION)
FIGURE 2 ASIA PACIFIC NEWBORN SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC DRY BLOOD SPOT TEST SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 4 NEONATAL MORTALITY RATE (PER 1000 LIVE BIRTHS) 2006-2016
FIGURE 5 FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2015
FIGURE 6 ASIA PACIFIC NEWBORN SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 7 ASIA PACIFIC HEARING SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 8 ASIA PACIFIC NEWBORN DISORDER SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 9 ASIA PACIFIC PULSE OXIMETRY SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 10 ASIA PACIFIC NEWBORN SCREENING REAGENTS & ASSAY KITS MARKET 2018-2026 ($ MILLION)
FIGURE 11 ASIA PACIFIC HEARING SCREENING TEST MARKET 2018-2026 ($ MILLION)
FIGURE 12 ASIA PACIFIC CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET 2018-2026 ($ MILLION)
FIGURE 13 ASIA PACIFIC DRY BLOOD SPOT TEST MARKET 2018-2026 ($ MILLION)
FIGURE 14 ASIA PACIFIC HEARING SCREEN TECHNOLOGY MARKET 2018-2026 ($ MILLION)
FIGURE 15 ASIA PACIFIC ELECTROPHORESIS MARKET 2018-2026 ($ MILLION)
FIGURE 16 ASIA PACIFIC TANDEM MASS SPECTROMETRY MARKET 2018-2026 ($ MILLION)
FIGURE 17 ASIA PACIFIC PULSE OXIMETRY TECHNOLOGY MARKET 2018-2026 ($ MILLION)
FIGURE 18 ASIA PACIFIC DNA BASED ASSAYS MARKET 2018-2026 ($ MILLION)
FIGURE 19 ASIA PACIFIC ENZYMES & IMMUNOASSAYS MARKET 2018-2026 ($ MILLION)
FIGURE 20 INVESTMENT PROPOSITION OF ASIA PACIFIC NEWBORN SCREENING MARKET BY COUNTRY -2017
FIGURE 21 INVESTMENT PROPOSITION OF ASIA PACIFIC NEWBORN SCREENING MARKET BY TECHNOLOGY – 2017
FIGURE 22 UNITED STATES NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 23 CHINA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 24 INDIA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 25 JAPAN NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 26 AUSTRALIA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 27 REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 28 MARKET SHARE ANALYSIS OF ASIA PACIFIC NEWBORN SCREENING MARKET, 2017



【レポートのキーワード】

新生児スクリーニング

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 新生児スクリーニングのアジア市場予測2018-2026(ASIA PACIFIC NEWBORN SCREENING MARKET FORECAST 2018-2026 )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆